Sex-specific gene regulation of neuronal chloride co-transporter, kcc2

神经元氯协同转运蛋白 kcc2 的性别特异性基因调控

基本信息

  • 批准号:
    7841928
  • 负责人:
  • 金额:
    $ 19.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-15 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chronic pathological pain and certain epileptic syndromes are neuropsychiatric disorders that share an increased female prevalence and refractoriness to treatment. The latter feature is considered to be linked to pathologically increased neuronal excitability caused by increased neuronal chloride (Cl-), which in turn is rooted in down-regulation of the dominant neuronal Cl--transporter, KCC2, which extrudes Cl-. Here we propose experiments to elucidate sex-specific regulation of the kcc2 gene by estrogens, based on a hypothesis that neuronal Cl- is dysregulated in response to neuronal injury in a sexually dimorphic manner, with the consequence of rendering women more susceptible to the above diseases. We have obtained exciting preliminary results (1) showing that kcc2 transcription is regulated by the repressor REST/NRSF which binds to a novel RE1/NRSE DNA binding site in kcc2 regulatory regions, (2) demonstrating this regulation to underlie the early developmental transformation of GABAergic transmission from excitatory to inhibitory, (3) developing a novel method to culture cortical primary neurons from individual rat E17 embryos which are being sex-typed by X-and Y-chromosome specific DNA markers. The latter method, straightforward yet possibly a groundbreaking novelty, permits strictly separate female vs. male primary cortical neuronal culture. We intend to elaborate molecular mechanisms how neuronal Cl- and KCC2 are regulated sex-specifically by exposing male vs. female neurons to 17-¿-estradiol and xenobiotic estrogen-mimetics. For this, we will electroporate kcc2 reporter gene constructs, wildtype and mutated for binding sites, driving a secreted luciferase reporter, which will facilitate establishment of a time-course of kcc2 transcription. For direct determination of Cl-, the fluorescent Cl--indicator clomeleon will be co-transfected. Cultures will be exposed to physiologically relevant concentrations of estradiol and practically relevant concentrations of xeno-estrogens (coumestrol, bisphenol-A, dieldrin). Use of the latter compounds will allow us to address modulation of estrogen responses by these ubiquitous compounds. Any sex-specific regulation will be confirmed in primary cultures derived from gene-targeted mice (estrogen-receptor (ER)-a, -¿ and non-classical-ER-knockin). These experiments will be conducted in a highly collaborative environment at Duke University, involving molecular and physiology neuroscience labs, in addition molecular endocrinology and environmental toxicology input. Results can be expected to shed new light on a fundamental matter, neuronal Cl--regulation, which very likely has sex-specific regulation as a basis for increased female prevalence in therapy-refractory neuropsychiatric diseases. PUBLIC HEALTH RELEVANCE: Neuronal chloride dictates nerve cells' excitability, and is reduced in chronic pathological pain as well as in certain forms of epilepsy, diseases characterized by therapeutic refractoriness and strong female preponderance. Experiments are described that will elucidate the regulation of the dominant electroneutral chloride transporter of mature neurons, KCC2. Estrogen and xenobiotic estrogen-mimetics will be used for stimulation of primary cortical neurons in culture, which will be maintained strictly separate for male vs. female, based on a novel methodology platform described here. Neurons derived from late-pregnancy embryos of rats and mice, the latter genetically encoded to lack functional estrogen-receptors, will be subjected to assays probing function and regulation of the kcc2 gene, namely reporter gene assays and measurement of neuronal chloride.
描述(由申请人提供):慢性病理性疼痛和某些癫痫综合征是女性患病率和治疗难治性增加的神经精神疾病。后一个特征被认为与神经元氯化物(Cl-)增加引起的病理性神经元兴奋性增加有关,而神经元氯化物(Cl-)增加又根源于主要神经元Cl-转运体KCC 2(其挤出Cl-)的下调。在这里,我们提出的实验来阐明性别特异性调节的kcc 2基因的雌激素,基于一个假设,即神经元Cl-是失调的神经元损伤的性二型的方式,使妇女更容易患上上述疾病的后果。我们已经获得了令人兴奋的初步结果:(1)表明kcc 2转录受阻遏物REST/NRSF的调控,该阻遏物与kcc 2调控区的一个新的RE 1/NRSE DNA结合位点结合,(2)证明这种调控是GABA能传递从兴奋性到抑制性的早期发育转变的基础,(3)建立了一种新的方法,从E17胚胎中培养皮层原代神经元,并通过X和Y染色体特异性DNA标记进行性别分型。后一种方法,简单,但可能是一个突破性的新奇,允许严格分开的女性与男性的初级皮层神经元文化。我们打算详细阐述神经元Cl-和KCC 2是如何通过将雄性与雌性神经元暴露于17-<$-雌二醇和异源性雌激素模拟物来进行性别特异性调节的分子机制。为此,我们将电穿孔kcc 2报告基因构建体,野生型和突变的结合位点,驱动分泌的荧光素酶报告基因,这将有助于建立kcc 2转录的时间过程。为了直接测定Cl-,将共转染荧光Cl-指示剂clomeleon。将培养物暴露于生理相关浓度的雌二醇和实际相关浓度的异种雌激素(香豆雌酚、双酚A、狄氏剂)。使用后一种化合物将使我们能够解决这些普遍存在的化合物对雌激素反应的调节。将在源自基因靶向小鼠的原代培养物中确认任何性别特异性调节(雌激素受体(ER)-α、-β和非经典-ER-敲入)。这些实验将在杜克大学的高度协作环境中进行,涉及分子和生理学神经科学实验室,以及分子内分泌学和环境毒理学输入。结果可以预期揭示一个基本的问题,神经元Cl-调节,这很可能有性别特异性调节的基础上增加女性患病率的治疗难治性神经精神疾病的新的光。 公共卫生关系:神经元氯化物决定神经细胞的兴奋性,并且在慢性病理性疼痛以及某些形式的癫痫中减少,这些疾病的特征是治疗无效和女性优势。 实验描述,将阐明成熟神经元,KCC 2的占主导地位的电中性氯转运的调节。雌激素和异源性雌激素模拟物将用于刺激培养物中的原代皮质神经元,基于本文所述的新方法平台,其将严格区分雄性与雌性。来自大鼠和小鼠妊娠晚期胚胎的神经元,后者遗传编码为缺乏功能性雌激素受体,将进行检测探测kcc 2基因的功能和调节,即报告基因检测和神经元氯化物的测量。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Highly conductive carbon nanotube matrix accelerates developmental chloride extrusion in central nervous system neurons by increased expression of chloride transporter KCC2.
  • DOI:
    10.1002/smll.201201994
  • 发表时间:
    2013-04-08
  • 期刊:
  • 影响因子:
    13.3
  • 作者:
    Liedtke, Wolfgang;Yeo, Michele;Zhang, Hongbo;Wang, Yiding;Gignac, Michelle;Miller, Sara;Berglund, Ken;Liu, Jie
  • 通讯作者:
    Liu, Jie
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WOLFGANG B. LIEDTKE其他文献

WOLFGANG B. LIEDTKE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WOLFGANG B. LIEDTKE', 18)}}的其他基金

Resolving orofacial neuropathic pain evoked by compression of a trigeminal nerve branch using rationally integrated complementary approaches
使用合理整合的补充方法解决三叉神经分支受压引起的口面部神经性疼痛
  • 批准号:
    9703533
  • 财政年份:
    2020
  • 资助金额:
    $ 19.5万
  • 项目类别:
Engineering cartilage mechanotransduction for treatment of chondrocyte injury
工程软骨机械传导治疗软骨细胞损伤
  • 批准号:
    8622225
  • 财政年份:
    2014
  • 资助金额:
    $ 19.5万
  • 项目类别:
Controlling mechanical signal transduction to treat osteoarthritis
控制机械信号转导治疗骨关节炎
  • 批准号:
    8452839
  • 财政年份:
    2013
  • 资助金额:
    $ 19.5万
  • 项目类别:
IN-VIVO AIRWAY CHANGES MEDIATED BY TRPV4
TRPV4 介导的体内气道变化
  • 批准号:
    8363210
  • 财政年份:
    2011
  • 资助金额:
    $ 19.5万
  • 项目类别:
Role of trpv4 in trigeminally mediated nociception
trpv4 在三叉神经介导的伤害感受中的作用
  • 批准号:
    7904363
  • 财政年份:
    2009
  • 资助金额:
    $ 19.5万
  • 项目类别:
COPAS BIOSORT Worm Sorter
COPAS BIOSORT 蠕虫分选机
  • 批准号:
    7795521
  • 财政年份:
    2009
  • 资助金额:
    $ 19.5万
  • 项目类别:
Role of trpv4 in trigeminally mediated nociception
trpv4 在三叉神经介导的伤害感受中的作用
  • 批准号:
    7778496
  • 财政年份:
    2009
  • 资助金额:
    $ 19.5万
  • 项目类别:
Role of trpv4 in trigeminally mediated nociception
trpv4 在三叉神经介导的伤害感受中的作用
  • 批准号:
    7473897
  • 财政年份:
    2007
  • 资助金额:
    $ 19.5万
  • 项目类别:
Role of trpv4 in trigeminally mediated nociception
trpv4 在三叉神经介导的伤害感受中的作用
  • 批准号:
    7837737
  • 财政年份:
    2007
  • 资助金额:
    $ 19.5万
  • 项目类别:
Role of trpv4 in trigeminally mediated nociception
trpv4 在三叉神经介导的伤害感受中的作用
  • 批准号:
    8069929
  • 财政年份:
    2007
  • 资助金额:
    $ 19.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了